Corticotropin-releasing factor type II (CRF2) receptors in the bed nucleus of the stria terminalis modulate conditioned defeat in Syrian hamsters (Mesocricetus auratus)

Behavioral Neuroscience

Volumn 119, Issue 4, 2005, Pages 1042-1051

  Cooper, Matthew A ^a   Huhman, Kim L ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Antisauvagine 30; Anxiety; CRH; Fear; Social defeat

Indexed keywords

ANTISAUVAGINE 30; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1 ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2 ANTAGONIST; UNCLASSIFIED DRUG;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BED NUCLEUS OF STRIA TERMINALIS; CONDITIONED DEFEAT; CONDITIONING; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; FEAR; MALE; NERVE CELL NETWORK; NONHUMAN; RECEPTOR BLOCKING; SOCIAL BEHAVIOR; STRIA TERMINALIS; SUBMISSIVE BEHAVIOR; SYRIAN HAMSTER; TERRITORIALITY;

AGGRESSION; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); CRICETINAE; DOMINANCE-SUBORDINATION; DOSE-RESPONSE RELATIONSHIP, DRUG; INTERPERSONAL RELATIONS; MALE; MESOCRICETUS; PEPTIDE FRAGMENTS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEPTAL NUCLEI; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 25444498279     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.119.4.1042     Document Type: Article

References (51)

1. 1 receptors in amygdala. The Journal of Neuroscience, 22, 2926-2935.
2. Bale, T., Contarino, A., Smith, G., Chan, R., Gold, L., Sawchenko, P., et al. (2000). Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nature Genetics, 24, 410-414.
3. Bittencourt, J., & Sawchenko, P. (2000). Do centrally administered neuropeptides access cognate receptors? An analysis in the central corticotropin-releasing factor system. The Journal of Neuroscience, 20, 1142-1156.
4. Blanchard, D., Spencer, R., Weiss, S., Blanchard, R., McEwen, B., & Sakai, R. (1995). Visible burrow system as a model of chronic social stress: Behavioral and neuroendocrine correlates. Psychoneuroendocrinology, 20, 117-134.
5. Chalmers, D., Lovenberg, T., & De Souza, E. (1995). Localization of novel corticotropin-releasing factor receptor (CRH2) mRNA expression to specific subcortical nuclei in rat brain: Comparison with CRH1 receptor mRNA expression. Journal of Neuroscience, 15, 6340-6350.
6. Contarino, A., Dellu, F., Koob, G., Smith, G., Lee, K., Vale, W., & Gold, L. H. (1999). Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1. Brain Research, 835, 1-9.
7. Coste, S., Kesterson, R., Heldwein, K., Stevens, S., Heard, A., Hollis, J., et al. (2000). Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nature Genetics, 24, 403-409.
8. Deak, T., Nguyen, K., Ehrlich, A., Watkins, L., Spencer, R., & Maier, S. (1999). The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology, 140, 79-86.
9. Dunn, A., & Berridge, C. (1990). Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Research Review, 15, 71-100.
10. Faruzzi, A., & Huhman, K. (2003, November). The interaction of social experience and corticotropin releasing factor receptors in the expression of agonistic behavior [Abstract]. Poster session presented at the annual meeting of the Society for Neuroscience (Program No. 926.1). Retrieved from http://sfn.scholarone.com
11. Faruzzi, A., Young, L., & Huhman, K. (2004, October). Corticotropin releasing factor receptors and social defeat in Syrian hamsters [Abstract]. Poster session presented at the annual meeting of the Society for Neuroscience (Program No. 777.10). Retrieved from http://sfn. scholarone.com
12. Fendt, M., Koch, M., & Schnitzler, H. (1997). Corticotropin-releasing factor in the caudal pontine reticular nucleus mediates the expression of fear-potentiated startle in the rat. European Journal of Neuroscience, 9, 299-305.
13. Fleck, B., Grigoriadis, D., & Hoare, S. (2004, October). Kinetics of peptide and nonpeptide antagonist binding to the corticotropin-releasing factor (CRF) type 1 receptor [Abstract]. Poster session presented at the annual meeting of the Society for Neuroscience (Program No. 629.12). Retrieved from http://sfn.scholarone.com
14. Griebel, G., Perrault, G., & Sanger, D. (1998). Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology, 138, 55-66.
15. Griebel, G., Simiand, J., Steinberg, R., Jung, M., Gully, D., Roger, P., et al. (2002). 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3- fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist: II. Characterization in rodent models of stress-related disorders. Journal of Pharmacology and Experimental Therapeutics, 301, 333-345.
16. Hammack, S., Schmid, M., LoPresti, M., Der-Avakian, A., Pellymounter, M., Foster, A., et al. (2003). Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress. The Journal of Neuroscience, 23, 1019-1025.
17. Heinrichs, S., Lapsansky, J., Lovenberg, T., De Souza, E., & Chalmers, D. (1997). Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior. Regulatory Peptides, 71, 15-21.
18. Heinrichs, S., Pich, E., Miczek, K., Britton, K., & Koob, G. (1992). Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Research, 581, 190-197.
19. 125I-antisauvagine-30: A novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors. Neuropharmacology, 40, 114-122.
20. Ho, S., Takahashi, L., Livanov, V., Spencer, K., Lesher, T., Maciag, C., et al. (2001). Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor. Molecular Brain Research, 89, 29-40.
21. Huhman, K., Moore, T., Ferns, C., Mougey, E., & Meyerhoff, J. (1991). Acute and repeated exposure to social conflict in male golden hamsters: Increases in plasma POMC-peptides and cortisol and decreases in plasma testosterone. Hormones and Behavior, 25, 206-216.
22. Huhman, K., Solomon, M., Janicki, M., Harmon, A., Lin, S., Israel, J., Jasnow, A. M. (2003). Conditioned defeat in male and female Syrian hamsters. Hormones and Behavior, 44, 293-299.
23. Jasnow, A., Banks, M., Owens, E., & Huhman, K. (1999). Differential effects of two corticotropin-releasing factor antagonists on conditioned defeat in male Syrian hamsters (Mesocricetus auratus). Brain Research, 846, 122-128.
24. Jasnow, A., Cooper, M., & Huhman, K. (2004). N-methyl-D aspartate receptors in the amygdala are necessary for the acquisition and expression of conditioned defeat. Neuroscience, 123, 625-634.
25. Jasnow, A., Davis, M., & Huhman, K. (2004). Involvement of central amygdalar and bed nucleus of the stria terminalis corticotropin-releasing factor in behavioral responses to social defeat. Behavioral Neuroscience, 118, 1052-1061.
26. Jasnow, A., Brazen, D., Huhman, K., Nelson, R., & Demas, G. (2001). Acute and chronic social defeat suppresses humoral immunity of male Syrian hamsters (Mesocricetus auratus). Hormones and Behavior, 40, 428-433.
27. A receptors in the amygdala blocks the acquisition and expression of conditioned defeat in Syrian hamsters. Brain Research, 920, 142-150.
28. Jones, D., Kortekass, R., Slade, P., Middlemiss, D., & Hagan, J. (1998). The behavioral effects of corticotropin-releasing factor-related peptides in rats. Psychopharmacology, 138, 124-132.
29. Kishimoto, T., Radulovic, J., Radulovic, M., Lin, C., Schrick, C., Hooshmand, F., et al. (2000). Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nature Genetics, 24, 415-419.
30. Korte, S., Korte-Bouws, G., Bonus, B., & Koob, G. (1994). Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats. Physiology and Behavior, 56, 115-120.
31. Liebsch, G., Landgraf, R., Engelmann, M., Lorscher, P., & Holsboer, F. (1999). Differential behavioral effects of chronic infusion of CRH1 and CRH2 receptor antisense oligonucleotides into the rat brain. Journal of Psychiatric Research, 33, 153-163.
32. Liebsch, G., Landgraf, R., Gerstberger, R., Probst, J., Wotjak, C., Engelmann, M., et al. (1995). Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regulatory Peptides, 59, 229-239.
33. Meerlo, P., Overkamp, G., Daan, S., van den Hoofdakker, R., & Koolhaas, J. (1996). Changes in behavior and body weight following a single or double social defeat in rats. Stress, 1, 21-32.
34. Menzaghi, F., Howard, R., Heinrichs, S., Vale, W., Rivier, J., & Koob, G. (1994). Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. Journal of Pharmacology and Experimental Therapeutics, 269, 564-572.
35. Morin, L. P., & Wood, R. I. (2001). A stereotaxic atlas of the golden hamster brain. New York: Academic Press.
36. Nijsen, M., Croiset, G., Stam, R., Bruijnzeel, A., Diamant, M., de Wied, D., Wiegant, V. M. (2000). The role of the CRH type 1 receptor in autonomic responses to corticotropin-releasing hormone in the rat. Neuropsychopharmacology, 22, 388-399.
37. Okuyama, S., Chaki, S., Kawashima, N., Suzuki, Y., Ogawa, S., Nakazato, A., et al. (1999). Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001. Journal of Pharmacology and Experimental Therapeutics, 289, 926-935.
38. Pelleymounter, A., Joppa, M., Ling, N., & Foster, A. (2002). Pharmacological evidence supporting a role for central corticotropin-releasing factor2 receptors in behavioral, but not endocrine, response to environmental stress. The Journal of Pharmacology and Experimental Therapeutics, 302, 145-152.
39. Potegal, M., Huhman, K., Moore, T., & Meyerhoff, J. (1993). Conditioned defeat in the Syrian golden hamster. Behavioral and Neural Biology, 60, 93-102.
40. Radulovic, J., Ruhmann, A., Liepold, T., & Spiess, J. (1999), Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: Differential roles of CRF receptors 1 and 2. Journal of Neuroscience, 19, 5016-5025.
41. Risbrough, V., Hauger, R., Pelleymounter, A., & Geyer, M. (2003). Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology, 170, 178-187.
42. Ruhmann, A., Bonk, I., Lin, C., Rosenfeld, M., & Spiess, J. (1998). Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): Development of CRFR2b-selective antisauvagine-30. Proceedings of the National Academy of Science USA, 95, 15264-15269.
43. Sapolsky, R. (1989). Hypercortisolism among socially subordinate wild baboons originates at the CNS level. Archives of General Psychiatry, 46, 1047-1051.
44. Schulz, D., Mansbach, R., Sprouse, J., Braselton, J., Collins, J., & Corman, M. (1996). CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proceedings of the National Academy of Science USA, 93, 10477-10482.
45. Sekino, A., Ohata, H., Mano-Otagiri, A., Arai, K., & Shibasaki, T. (2004). Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats. Psychopharmacology (Berlin), 176, 30-38.
46. Seymour, P., Schmidt, A., & Schulz, D. (2003). The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: A review. CNS Drug Reviews, 9, 57-96.
47. Smith, G., Aubry, J., Dellu, F., Contarino, A., Bilezikjian, L., Gold, L., et al. (1998). Corticotropin-releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron, 20, 1093-1102.
48. 2 receptors produces anxiolytic behavior in animal models of anxiety. Brain Research, 902, 135-142.
49. Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J., Stalla, G., et al. (1998). Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genetics, 19, 162-166.
50. Valdez, G., Inoue, K., Koob, G., Rivier, J., Vale, W., & Zorrilla, E. (2002). Human urocortin II: Mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Research, 943, 142-150.
51. Van Pett, K., Viau, V., Bittencourt, J. C., Chan, R. K., Li, H. Y., Arias, C., et al. (2000). Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. Journal of Comparative Neurology, 428, 191-212.